查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591897

人類生殖技術市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Human Reproductive Technologies Market by Type (Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination), Application (Fertility Preservation, Genetic Screening, Infertility Treatment), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人類生殖技術市場價值為298.4億美元，預計到2024年將達到318.2億美元，複合年成長率為6.66%，到2030年將達到468.9億美元。

人類生殖技術是旨在透過醫學和科學干預輔助人類生殖的多種治療方法和技術的集合。此範圍包括體外受精 (IVF)、人工授精、促排卵藥物、代孕、新基因組技術等。這些技術的需求主要是由於延遲分娩、生活方式因素和某些醫療狀況導致的不孕症盛行率不斷增加而推動的。從應用來看，廣泛應用於生育診所、醫院、醫療研究機構等。最終用途包括希望生育的個別夫妻、同性伴侶和尋求輔助生殖的單親父母。

主要市場統計
基準年[2023] 298.4億美元
預測年份 [2024] 318.2億美元
預測年份 [2030] 468.9億美元
複合年成長率（%） 6.66%

人們對生殖技術的認知和接受度不斷提高、醫學科學的進步以及政府對生育旅遊的支持性監管對市場產生了重大影響。此外，新興國家可支配收入的增加和醫療基礎設施的改善正在推動需求。然而，它也存在一些局限性，例如治療費用上漲、倫理和法律問題以及可能給患者帶來的心理壓力。挑戰包括影響技術採用的社會偏見和地區不同的法律體制。

潛在的成長機會在於技術進步，例如開發負擔得起且易於獲得的治療方法、將生殖技術與個人遺傳特徵相匹配的個人化醫療以及有效預測治療結果的人工智慧。對於希望利用這些機會的公司來說，投資研發以創建創新的生育解決方案、與醫療保健提供者建立夥伴關係以提供更廣泛的服務以及支持可及性和保險政策宣傳可能是一個戰略步驟。創新熱點包括非侵入性不孕症診斷、胚胎和配子冷凍保存以及用於患者參與和教育的行動醫療應用程式。該市場的特點是技術快速進步、競爭日益激烈，以及生物技術公司、製藥公司和醫療保健行業之間的潛在合作，以有效解決未滿足的需求，同時應對道德和監管環境。

市場動態：揭示快速發展的人類生殖技術市場的關鍵市場洞察

供需的動態交互作用正在改變人類生殖技術市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 生活方式的改變以及不孕症和不孕症相關疾病盛行率的上升
    • 旨在治療不孕症的醫療旅遊增加
    • 提高對不孕症治療的認知與接受度
  • 市場限制因素
    • 不孕症治療的費用高且保險範圍有限
  • 市場機會
    • 人類生殖技術的進步和創新可實現更有效的治療
    • 生殖技術創新的專利和版權
  • 市場挑戰
    • 有限的成功率和相關的健康風險

波特五力：駕馭人類生殖科技市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對人類生殖技術市場的影響

外部宏觀環境因素在塑造人類生殖技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人類生殖技術市場的競爭格局

對人類生殖技術市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣人類生殖技術市場供應商的績效評估

FPNV 定位矩陣是評估人類生殖技術市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，以規劃人類生殖技術市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對人類生殖技術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生活方式的改變以及不孕症和不孕症相關疾病的增加
      • 以不孕症治療為重點的醫療旅遊增加
      • 提高對不孕症治療的認知與接受度
    • 抑制因素
      • 不孕症治療費用高且保險範圍有限
    • 機會
      • 人類生殖技術的進步和創新可實現更有效的治療
      • 與生殖技術創新相關的專利和版權
    • 任務
      • 有限的成功率和相關的健康風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人類生殖科技市場：依類型

  • 輔助生殖技術
  • 體外受精
  • 子宮內人工授精
  • 胚胎著床前基因檢測
  • 代孕

第7章人類生殖科技市場：依應用分類

  • 保留生育能力
  • 基因檢測
  • 不孕症治療

第8章人類生殖科技市場：依最終使用者分類

  • 不孕不育治療診所
  • 醫院
  • 研究/學術機構

第9章美洲人類生殖技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區人類生殖技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲人類生殖技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AbbVie Inc.
  • Aurobindo Pharma
  • Bayer AG
  • CooperSurgical Fertility Solutions
  • Eli Lilly and Company
  • European Sperm Bank
  • Evofem Biosciences, Inc.
  • Ferring BV
  • GSK PLC
  • InSEM Fertility Solutions
  • INVO Bioscience
  • KG Medical Industries
  • Mankind Pharma
  • Merck KGaA
  • Microm UK Ltd.
  • Monash IVF Group
  • Pfizer Inc.
  • Pride Angel
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • V Conceive
  • Vitrolab AB
  • Voxtur Bio Ltd.
Product Code: MRR-69324464D214

The Human Reproductive Technologies Market was valued at USD 29.84 billion in 2023, expected to reach USD 31.82 billion in 2024, and is projected to grow at a CAGR of 6.66%, to USD 46.89 billion by 2030.

Human Reproductive Technologies are a diverse set of treatments and technologies aimed at assisting human reproduction through medical and scientific interventions. This scope includes in vitro fertilization (IVF), artificial insemination, fertility drugs, surrogacy, and emerging genomics technologies. The necessity for these technologies is primarily driven by the increasing prevalence of infertility due to delayed childbearing, lifestyle factors, and certain medical conditions. Application-wise, they are extensively utilized in fertility clinics, hospitals, and healthcare research institutions. End-use spans across individual couples desiring children, same-sex couples, and single parents seeking reproductive assistance.

KEY MARKET STATISTICS
Base Year [2023] USD 29.84 billion
Estimated Year [2024] USD 31.82 billion
Forecast Year [2030] USD 46.89 billion
CAGR (%) 6.66%

The market is significantly influenced by the growing awareness and acceptance of reproductive health technologies, advancements in medical sciences, and supportive government regulations for fertility tourism. Moreover, rising disposable income and better healthcare infrastructure in emerging economies drive demand. However, the market faces limitations such as high costs of treatment, ethical and legal concerns, and the potential for psychological stress among patients. Challenges include societal stigmas and varied legal frameworks across different regions impacting technology adoption.

Potential growth opportunities lie in developing affordable and accessible treatment options, personalized medicine adapting reproductive technologies to individual genetic profiles, and advancing technologies such as artificial intelligence to predict treatment outcomes effectively. For businesses looking to capitalize on these opportunities, investment in research and development to create innovative fertility solutions, forming partnerships with healthcare providers for wider service distribution, and advocating for policies that support accessibility and insurance coverage can be strategic steps. Innovation hotspots include non-invasive fertility diagnostics, embryo and gamete cryopreservation, and mobile health applications for patient engagement and education. The market is characterized by rapid technological advancements, increasing competition, and potential collaboration between biotechnology firms, pharmaceuticals, and healthcare sectors to address unmet needs effectively while navigating ethical and regulatory landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Reproductive Technologies Market

The Human Reproductive Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Changing lifestyles and rising prevalence of infertility and fertility-related disorders
    • Growing medical tourism for specialized fertility treatments
    • Increasing awareness and acceptance of fertility treatments
  • Market Restraints
    • High cost and limited insurance coverage for fertility treatments
  • Market Opportunities
    • Advancements and innovations in human reproductive technology for more effective treatment
    • Patents and copyrights for innovations in the reproductive technologies
  • Market Challenges
    • Limited success rates and associated health risks

Porter's Five Forces: A Strategic Tool for Navigating the Human Reproductive Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Reproductive Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Reproductive Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Reproductive Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Reproductive Technologies Market

A detailed market share analysis in the Human Reproductive Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Reproductive Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Reproductive Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Reproductive Technologies Market

A strategic analysis of the Human Reproductive Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Reproductive Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aurobindo Pharma, Bayer AG, CooperSurgical Fertility Solutions, Eli Lilly and Company, European Sperm Bank, Evofem Biosciences, Inc., Ferring B.V., GSK PLC, InSEM Fertility Solutions, INVO Bioscience, KG Medical Industries, Mankind Pharma, Merck KGaA, Microm UK Ltd., Monash IVF Group, Pfizer Inc., Pride Angel, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., V Conceive, Vitrolab AB, and Voxtur Bio Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Reproductive Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination, Preimplantation Genetic Testing, and Surrogacy.
  • Based on Application, market is studied across Fertility Preservation, Genetic Screening, and Infertility Treatment.
  • Based on End-User, market is studied across Fertility Clinics, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Changing lifestyles and rising prevalence of infertility and fertility-related disorders
      • 5.1.1.2. Growing medical tourism for specialized fertility treatments
      • 5.1.1.3. Increasing awareness and acceptance of fertility treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and limited insurance coverage for fertility treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and innovations in human reproductive technology for more effective treatment
      • 5.1.3.2. Patents and copyrights for innovations in the reproductive technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited success rates and associated health risks
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Reproductive Technologies Market, by Type

  • 6.1. Introduction
  • 6.2. Assisted Reproductive Technology
  • 6.3. In Vitro Fertilizartion
  • 6.4. Intrauterine Insemination
  • 6.5. Preimplantation Genetic Testing
  • 6.6. Surrogacy

7. Human Reproductive Technologies Market, by Application

  • 7.1. Introduction
  • 7.2. Fertility Preservation
  • 7.3. Genetic Screening
  • 7.4. Infertility Treatment

8. Human Reproductive Technologies Market, by End-User

  • 8.1. Introduction
  • 8.2. Fertility Clinics
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes

9. Americas Human Reproductive Technologies Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Reproductive Technologies Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Reproductive Technologies Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Aurobindo Pharma
  • 4. Bayer AG
  • 5. CooperSurgical Fertility Solutions
  • 6. Eli Lilly and Company
  • 7. European Sperm Bank
  • 8. Evofem Biosciences, Inc.
  • 9. Ferring B.V.
  • 10. GSK PLC
  • 11. InSEM Fertility Solutions
  • 12. INVO Bioscience
  • 13. KG Medical Industries
  • 14. Mankind Pharma
  • 15. Merck KGaA
  • 16. Microm UK Ltd.
  • 17. Monash IVF Group
  • 18. Pfizer Inc.
  • 19. Pride Angel
  • 20. Sandoz International GmbH
  • 21. Sun Pharmaceutical Industries Ltd.
  • 22. Teva Pharmaceutical Industries Ltd.
  • 23. V Conceive
  • 24. Vitrolab AB
  • 25. Voxtur Bio Ltd.

LIST OF FIGURES

  • FIGURE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZARTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023